📣 VC round data is live. Check it out!
- Public Comps
- abrdn Life Sciences
abrdn Life Sciences Valuation Multiples
Discover revenue and EBITDA valuation multiples for abrdn Life Sciences and similar public comparables like Djerriwarrh Investments, Deutsche Beteiligungs, Chrysalis Investments, CoinShares and more.
abrdn Life Sciences Overview
About abrdn Life Sciences
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund’s Investment Adviser to have the potential for above-average growth.
Founded
1992
HQ

Employees
N/A
Website
Sectors
Financials (FY)
EV
$523M
Valuation Multiples
Start free trialabrdn Life Sciences Financials
abrdn Life Sciences reported last fiscal year revenue of $86M.
In the same fiscal year, abrdn Life Sciences generated $86M in net income.
abrdn Life Sciences P&L
In the most recent fiscal year, abrdn Life Sciences reported revenue of $86M and net income of $86M.
abrdn Life Sciences is profitable as of last fiscal year, with net margin of 99%.
Financial data powered by Morningstar, Inc.
abrdn Life Sciences Stock Performance
abrdn Life Sciences has current market cap of $523M, and enterprise value of $523M.
Market Cap Evolution
abrdn Life Sciences' stock price is $17.19.
abrdn Life Sciences share price decreased by 1.8% in the last 30 days, and increased by 44.5% in the last year.
abrdn Life Sciences has an EPS (earnings per share) of $2.81.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $523M | $523M | 0.0% | -1.8% | 3.2% | 44.5% | $2.81 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free Trialabrdn Life Sciences Valuation Multiples
abrdn Life Sciences trades at 6.1x EV/Revenue multiple.
abrdn Life Sciences Financial Valuation Multiples
As of May 25, 2026, abrdn Life Sciences has market cap of $523M and EV of $523M.
abrdn Life Sciences has a P/E ratio of 6.1x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified abrdn Life Sciences Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


abrdn Life Sciences Margins & Growth Rates
In the most recent fiscal year, abrdn Life Sciences reported net margin of 99%.
abrdn Life Sciences Margins
abrdn Life Sciences Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
abrdn Life Sciences Operational KPIs
Data powered by FactSet, Inc. and Morningstar, Inc.
abrdn Life Sciences Competitors
abrdn Life Sciences competitors include Djerriwarrh Investments, Deutsche Beteiligungs, Chrysalis Investments, CoinShares, Eagle Point Credit, SPARX Group, Hedge Brasil Shopping FII, Brait, Nextensa and SBI Global Asset Management.
Most abrdn Life Sciences public comparables operate across Asset Management.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 17.1x | — | — | — | |||
| 5.7x | 6.8x | 16.0x | 15.0x | |||
| 3.7x | 68.4x | — | — | |||
| — | — | — | — | |||
| 4.0x | 4.2x | — | — | |||
| 4.2x | 3.8x | 9.0x | — | |||
| 9.6x | — | 8.0x | — | |||
| 18.8x | — | — | — | |||
This data is available for Pro users. Sign up to see all abrdn Life Sciences competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout abrdn Life Sciences
| When was abrdn Life Sciences founded? | abrdn Life Sciences was founded in 1992. |
| Where is abrdn Life Sciences headquartered? | abrdn Life Sciences is headquartered in United States. |
| Is abrdn Life Sciences publicly listed? | Yes, abrdn Life Sciences is a public company listed on NYSE. |
| What is the stock symbol of abrdn Life Sciences? | abrdn Life Sciences trades under HQL ticker. |
| Who are competitors of abrdn Life Sciences? | abrdn Life Sciences main competitors include Djerriwarrh Investments, Deutsche Beteiligungs, Chrysalis Investments, CoinShares, Eagle Point Credit, SPARX Group, Hedge Brasil Shopping FII, Brait, Nextensa, SBI Global Asset Management. |
| What is the current market cap of abrdn Life Sciences? | abrdn Life Sciences' current market cap is $523M. |
| What is the current revenue of abrdn Life Sciences? | abrdn Life Sciences' last fiscal year revenue is $86M. |
| What is the current EV/Revenue multiple of abrdn Life Sciences? | Current revenue multiple of abrdn Life Sciences is 6.1x. |
| Is abrdn Life Sciences profitable? | No, abrdn Life Sciences is not profitable. |
| How many companies abrdn Life Sciences has acquired to date? | abrdn Life Sciences hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies abrdn Life Sciences has invested to date? | abrdn Life Sciences hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to abrdn Life Sciences
Lists including abrdn Life Sciences
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.